Dr. Christian Behrenbruch, CEO of Telix Pharmaceuticals Limited, to speak at Jefferies 2019 London Healthcare Conference

LONDON (United Kingdom) – November 19, 2019. Dr. Christian Behrenbruch, CEO of  Telix Pharmaceuticals Limited, to speak at Jefferies 2019 London Healthcare Conference.

Dr. Christian Behrenbruch, CEO of  Telix Pharmaceuticals Limited will speak at Jefferies 2019 London Healthcare Conference. This year marks the 10th anniversary of now the largest healthcare-dedicated conference in Europe, which in 2018, hosted 500 participating companies, 2,000 attendees and 5,000 business-to-business and investor meetings.

The event will again feature leading public and private companies from the pharmaceuticals, biotechnology, generics, consumer health, animal health, medical technology, and healthcare services sectors from the United States, Europe, Africa, Middle East, Latin America, Russia, India, Israel, Australia, China, and Japan.

Representing Telix Pharmaceuticals Limited, Chris Behrenbruch will be speaking at 5:20 p.m. GMT Thursday, November 21, 2019, which can be viewed via live stream at www.jefferies.com/112019. This same link can be used for a recorded version post-presentation.

Registration for the webcast can be accessed here.